Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (351-360 of 773) with videos related to

Pageof 78
Sort By:
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Leukemia|April 25, 2020
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaHartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, et al.
Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.
American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
The Journal of Rheumatology|January 17, 2015
Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritisXiaoli Deng, Cynthia S Crowson, S Vincent Rajkumar, et al.
Blood|January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyOla Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2011
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasoneJesús F San-Miguel, Meletios A Dimopoulos, Edward A Stadtmauer, et al.
Pageof 78

Showing results (351-360 of 773) with videos related to

Sort By:
Pageof 78
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Leukemia|April 25, 2020
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaHartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, et al.
Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.
American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
The Journal of Rheumatology|January 17, 2015
Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritisXiaoli Deng, Cynthia S Crowson, S Vincent Rajkumar, et al.
Blood|January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyOla Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 29, 2011
Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasoneJesús F San-Miguel, Meletios A Dimopoulos, Edward A Stadtmauer, et al.
Pageof 78